Yong-hua Zhao

246 Xuefu Road, Nangang District
Harbin, 150086, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication

Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: December 17, 2013

Silent information regulator 1 inhibition induces lipid metabolism disorders of hepatocytes and enhances hepatitis C virus replication.

Silent information regulator 1 inhibition induces lipid metabolism disorders of hepatocytes and enhances hepatitis C virus replication.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 08, 2012

Inhibition of silent information regulator 1 induces glucose metabolism disorders of hepatocytes and enhances hepatitis C virus replication.

Inhibition of silent information regulator 1 induces glucose metabolism disorders of hepatocytes and enhances hepatitis C virus replication.

Journal: Hepatology international

Published: September 29, 2012

Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.

Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 29, 2012

A study of the relationship between neutropenia and clinical infection risk during treatment with peginterferon alfa-2a and ribavirin for chronic hepatitis C

A study of the relationship between neutropenia and clinical infection risk during treatment with peginterferon alfa-2a and ribavirin for chronic hepatitis C

Journal: Zhonghua nei ke za zhi

Published: April 12, 2012

Efficacy and factors influencing treatment with peginterferon alpha-2a and ribavirin in elderly patients with chronic hepatitis C.

Efficacy and factors influencing treatment with peginterferon alpha-2a and ribavirin in elderly patients with chronic hepatitis C.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: April 10, 2012

Impact of age and sex on virologic responses of peginterferon alfa-2a and ribavirin treatment in chronic hepatitis C

Impact of age and sex on virologic responses of peginterferon alfa-2a and ribavirin treatment in chronic hepatitis C

Journal: Zhonghua nei ke za zhi

Published: February 16, 2012

The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.

The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.

Journal: European journal of gastroenterology & hepatology

Published: October 06, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026